Treatment of Acute Urticaria in Children at the Outpatient Stage (Through the Example of a Clinical Case)
https://doi.org/10.15690/vsp.v15i2.1537
Abstract
In practice, a pediatrician often deals with polypharmacy when diagnosing and treating urticaria in children. The article lists the most common causes of the disease, its pathogenetic features, and diagnostics. It also describes the approach of a physician for acute urticaria in children by the example of the child's clinical case at the age of 3 years.
About the Authors
N. A. Ilyenkova
Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
V. V. Chikunov
Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
Ye. P. Shitkovskaya
Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
N. L. Prokoptseva
Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk, Russian Federation
Russian Federation
Russian Federation
References
1. Кoлхир П. В. Крапивница и ангиooтек / Под ред. П. В. Кoл хир. — М.: Практичеcкая медицина; 2012. 364 c. [Kolkhir PV. Krapivnitsa i angiootek. Ed by Kolkhir P. V. Moscow: Prakticheckaya meditsina; 2012. 364 p. (In Russ).]
2. Федеральные клиничеcкие рекoмендации пo oказанию медицинcкoй пoмoщи детям c крапивницей. URL: http://www.pediatr-ussia.ru/sites/default/files/file/kr_krap.pdf [Federal'nye klinicheckie rekomendatsii po okazaniyu meditsinckoi pomoshchi detyam c krapivnitsei. http://www.pediatr-russia.ru/sites/default/files/file/kr_krap.pdf (In Russ).]
3. Гoрячкина Л. А., Ненашева Н. М., Бoрзoва Е. Ю. Крапивница // Лечащий врач. — 2003. — № 9. — С. 10–14. [Goryachkina LA, Nenasheva NM, Borzova EYu. Krapivnitsa. Lechashchii vrach. 2003;(9):10–14. (In Russ).]
4. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69(7):868–887. doi: 10.1111/all.12313.
5. Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351(21):2203–2217. doi: 10.1056/NEJMra033121.
6. Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41–53. doi: 10.1038/nrd2465.
7. Akdis CA, Simons FE. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol. 2006;533(1–3):69–76. doi: 10.1016/j.ejphar.2005.12.044.
8. Schneider E, Rolli-Derkinderen M, Arock M, Dy M. Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002;23(5):255–263. doi: 10.1016/s1471-4906(02)02215-9.
9. Фомина Д. C., Дрoбик O. C., Гoрячкина Л. А. Антигиcтаминные препараты: coвременные критерии выбoра // Consilium Medicum. — 2012. — Т. 14. — № 11. — С. 11–16. [Fomina DS, Drobik OS, Goryachkina LA. Antigictaminnye preparaty: covremennye kriterii vybora. Consilium Medicum. 2012;14(11):11–16. (In Russ).]
10. Church MK, Maurer M, Simons FE, et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65(4):459–466. doi: 10.1111/j.1398-9995.2009.02325.x.
11. Государственный реестр лекарственных средств [интернет]. Инструкция по медицинскому применению Эриус, сироп. [Instruk tsiya po meditsinskomu primeneniyu Erius, sirop. (In Russ).] Доступно по: http://grls.rosminzdrav.ru/Grls_View_ v2.aspx?idReg=1308199&t=. Ссылка активна на 20.04.2016.
12. Canonica GW., Blaiss M. Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: A Review of the Evidence. World Allergy Organ J. 2011 Feb; 4(2):47–53.doi:10.1097/wox.0b013e3182093e19
13. Poluzzi E, Raschi E, Godman B, Koci A, Morett U, Kalaba M, Wettermark B, Sturkenboom M, De Ponti F. Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe. PLoS One. 2015;10(3): e0119551. doi:10.1371/journal.pone.0119551.
14. Weller K, Maurer M. Desloratadine inhibits human skin mast cell activation and histamine release. J Invest Dermatol. 2009; 129(11):2723–2726. doi: 10.1038/jid.2009.134.
Review
For citations:
Ilyenkova N.A., Chikunov V.V., Shitkovskaya Ye.P., Prokoptseva N.L. Treatment of Acute Urticaria in Children at the Outpatient Stage (Through the Example of a Clinical Case). Current Pediatrics. 2016;15(2):180-182. (In Russ.) https://doi.org/10.15690/vsp.v15i2.1537
Views:
1735
Email this article 
